27 Apr Adco-Napacod tablets (Paracetamol 500 mg and Codeine Phosphate 10mg)
| Company name & Address: |
registration number |
Batch number(s) |
Expiry date |
Pack size |
First distributed |
Re-call Classification |
Re-call Date |
| Adcock Ingram Limited.
1 New Road, Midrand, 1685 |
B/2.8/1401 |
AD0433
AC1264 |
02-2026
06-2025 |
1000’s |
25 June-2021
08 Oct-2020 |
Class II Type B |
23 June 2022 |
Reason for recall
The products are being recalled due to quality defect: the company received customer complaints reporting discoloration of tablets and/or discoloured silica gel (complaints were either about discoloured silica gel sachets only or discoloured silica gel sachets and tablets with which the sachets had direct contact).
Advice to HCPs/Distributors/Public:
Affected stock has been blocked for distribution and the product placed on hold at Adcock Ingram distribution centers.
Proposed action taken and its urgency: SAHPRA approved recall letter distributed to all distribution points, recall Initiated.
Reporting side effects
Public and healthcare professionals are encouraged to report any side effects after using a health product or after immunisation by using the Med Safety App. Your report will contribute to our monitoring of these health products.